Introduction
The bronchial epithelium is considered to play an important role in initiating and perpetuating inflammatory and immunological reactions by production of a variety of inflammatory mediators. Therefore, it is thought that human bronchial epithelial cells (HBEC) may play a role in inflammatory pulmonary diseases such as asthma. Upon in vitro stimulation with inflammatory agents such as interleukin-l[ (IL-113), tumour necrosis factor-a (TNF-a) and lipopolysaccharide (LPS), HBEC are able to produce several cytokines, such as IL-1, interleukin-6 (IL-6), interleukin-8 (IL-8), granulocyte-macrophage colonystimulating factor (GM-CSF) and monocyte chemoattractant factor-1 (MCP-1).
Furthermore, HBEC exposed to various stimuli in vitro release several arachidonic acid metabolites, including 15-hydroxyeicosatetraenoic acid , prostaglandin E2 (PGE2) and 6-keto-prostaglandin F= . 4'5 In addition to these pro-inflammatory properties, HBEC could also be involved in anti-inflammatory reactions through the production of potential anti-inflammatory proteins, e.g. lipocortins.
Lipocortin I and II (annexin I and II) are members of the annexin family of Cai+-depen dent phospholipid-binding proteins. Biological evidence suggests that at least some members of this family are glucocorticoid inducible proteins with anti-inflammatory properties7 It has been proposed that lipocortins I and II mediate part of the immunosuppressive activity of glucocorticoids by inhibiting phospholipase A2 (PLA2) activity, hereby preventing eicosanoid production. 8 In some recent studies, however, the induction of lipocortin I and II by glucocorticoids was not obseeeed. [9] [10] [11] Other biological functions for lipocortins have also been reported, such as the regulation of cell differentiation and growth, and a role in the central nervous system and neuroendocrine system (reviewed in Reference 12) .
Animal studies have suggested that the lung is a rich source of lipocortin I. [13] [14] [15] [16] In the human lung, lipocortin synthesis has been described in blood leucocytes and alveolar macrophages. 7' In cultured human tracheal submucosal gland cells production of lipocortin-like proteins have been found. 19 However, to our knowledge, no data are available on the presence of lipocortins in HBEC. (Fig. 2) . Fifty and 80% of cultured HBEC (n 3) were positive for intracellular lipocortin I and II, respectively. A representative experiment is shown in Fig. 2 (Fig. 4) . PGE2
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